These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 740580)

  • 21. The relationship between oestrogen status and bone loss in post-menopausal women.
    Nordin BE; Horsman A; Brook R; Williams DA
    Clin Endocrinol (Oxf); 1976; 5 Suppl():353S-361S. PubMed ID: 1052784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SPINAL OSTEOPOROSIS AND THE MENOPAUSE.
    JASANI C; NORDIN BE; SMITH DA; SWANSON I
    Proc R Soc Med; 1965 Jun; 58(6):441-4. PubMed ID: 14291272
    [No Abstract]   [Full Text] [Related]  

  • 23. The presence of dl-, d- and l-norgestrel and their metabolites in the plasma of women.
    Sisenwine SF; Kimmel HB; Liu AL; Ruelius HW
    Contraception; 1975 Sep; 12(3):339-53. PubMed ID: 1164851
    [No Abstract]   [Full Text] [Related]  

  • 24. [About the effect of oestradiol crystal suspensions in menopausal women].
    HOFFMANN F
    Dtsch Med Wochenschr; 1947 Sep; 72(33-34):481-3. PubMed ID: 20268610
    [No Abstract]   [Full Text] [Related]  

  • 25. The orientation of the C-17-OH group of oestradiol in relation to its antiatherogenic activity.
    MALINOW MR; GIMENO AL; PELLEGRINO-IRALDI AA; FERNANDEZ-GIMENO MA; BUR GE; LACUARA JL; MOGUILEVSKY JA
    J Endocrinol; 1960 Sep; 21():1-7. PubMed ID: 13765806
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of ethinyl oestradiol on calcium and bone metabolism in peri- and postmenopausal women.
    Marshall RW; Selby PL; Chilvers DC; Hodgkinson A
    Horm Metab Res; 1984 Feb; 16(2):97-9. PubMed ID: 6706290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of two different progestins (cyproterone acetate and norgestrel), administered in a cyclical estradiol valerate regimen, on markers of bone turnover.
    Prelević GM; Beljić T; Balint-Perić L; Petrović J; Elliesen J
    Gynecol Endocrinol; 1994 Sep; 8(3):209-14. PubMed ID: 7847107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sequence therapy with estradiol valerate-norgestrel at menopause. A double-blind investigation].
    Davidsen PC; Secher NJ; Pedersen GT; Christensen NC
    Ugeskr Laeger; 1974 Aug; 136(32):1805-8. PubMed ID: 4605940
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
    Arrenbrecht S; Caubel P; Garnero P; Felsenberg D
    Maturitas; 2004 Jul; 48(3):197-207. PubMed ID: 15207885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term post-menopausal hormone therapy and serum HDL-C, total cholesterol and triglycerides.
    Vilska S; Punnonen R; Rauramo L
    Maturitas; 1983 Aug; 5(2):97-104. PubMed ID: 6415365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium and osteoporosis.
    Nordin BE; Polley KJ; Need AG; Morris HA; Horowitz H
    Ann Chir Gynaecol; 1988; 77(5-6):212-8. PubMed ID: 3076047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of oestradiol valerate and cyclic oestradiol valerate/DL-norgestrel on calcium metabolism.
    Crilly RG; Marshall DH; Nordin BE
    Postgrad Med J; 1978; 54 Suppl 2():47-9. PubMed ID: 740580
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.